CliffBio
small molecule

LEXETTE

HALOBETASOL PROPIONATE

Loss of exclusivityMay 2037latest FDA-listed patent expiry
CompanyMayne Pharma →View the full company profile on CliffBio

Drug detail

Brand nameLEXETTE
Active ingredientHALOBETASOL PROPIONATE
Strength0.05%
Dosage formAEROSOL, FOAM
RouteTOPICAL
ModalitySmall molecule
FDA approvalMay 2018
Marketing statusDISCN

Listed patents

PatentExpiresType
10857159*PEDMay 2037—
11020407November 2036product
10857159November 2036product

More from Mayne Pharma

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

LEXETTE patent cliff — loss of exclusivity May 2037 | CliffBio